MedPath
NMPA Approval

Ibuprofen Suspension Drops

国药准字H20249667

December 1, 2024

Drug Information

布洛芬混悬滴剂

口服混悬剂

30ml:1.2g

化学药品

December 1, 2024

Company Information

Applicant Company

江苏省海门经济技术开发区定海路688号

Manufacturing Company

江苏省海门经济技术开发区定海路688号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

布洛芬混悬滴剂 - NMPA 批准文号 | MedPath